Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.64
+0.240010.00%
Volume:3.41M
Turnover:8.89M
Market Cap:415.92M
PE:5.44
High:2.71
Open:2.46
Low:2.43
Close:2.40
Loading ...
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 04, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 05, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 04, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2021

Major Issues Report

8-K - Current report